RSS Feeds Breaking News Premium Content All Content Breaking News Galapagos Partners With NecstGen to Support Decentralized Cell Therapy Manufacturing Ibex AI-Driven Prostate Cancer Screening Test Nets FDA Clearance Mustang Bio Closes $8M Public Offering Immuneering Partners with Regeneron to Study Combined MEK, PD-1 Inhibitor Therapy in Solid Tumors Maze Therapeutics Doses First Patient in Phase II APOL1 Inhibitor Kidney Disease Trial In Brief This Week: Ocugen, Acrivon, Myriad Genetics, Ariceum, Arbor Biotechnologies
